e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia
Woyda K., Koebrich S., Reiss I., Rudloff S., Pullamsetti S. S., Ruhlmann A., Weissmann N., Ghofrani H. A., Gunther A., Seeger W., Grimminger F., Morty R. E., Schermuly R. T.
Source:
Eur Respir J 2009; 33: 861-870
Journal Issue:
April
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Woyda K., Koebrich S., Reiss I., Rudloff S., Pullamsetti S. S., Ruhlmann A., Weissmann N., Ghofrani H. A., Gunther A., Seeger W., Grimminger F., Morty R. E., Schermuly R. T.. Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia. Eur Respir J 2009; 33: 861-870
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
Related content which might interest you:
Apelin attenuates neonatal hyperoxic lung and heart injury in a rat model of bronchopulmonary dysplasia
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Ambrisentan attenuates lung and heart injury in a rat model of bronchopulmonary dysplasia
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury
Source: Eur Respir J 2008; 31: 633-644
Year: 2008
Neonatal chronic lung disease and its long-term consequences
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=99
Year: 2002
Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine
Source: Eur Respir J 2013; 41: 966-973
Year: 2013
Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury
Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant
Year: 2011
Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
The influence of intermittent CPAP on hyperoxic lung injury in a preterm rabbit model of bronchopulmonary dysplasia
Source: International Congress 2019 – Molecular and experimental paediatric lung disease
Year: 2019
Antenatal infection in the rabbit impairs post-natal growth and lung alveolarisation
Source: Eur Respir J 2008; 32: 1520-1528
Year: 2008
KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury},
Source: Eur Respir J 2012; 40: 939-948
Year: 2012
Delayed neutrophil apoptosis may predispose to lung injury in chronic lung disease of prematurity
Source: Eur Respir J 2007; 30: Suppl. 51, 393s
Year: 2007
Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Does early injury of the neonatal lung contribute to premature lung aging?
Source: International Congress 2019 – Early origins of lung disease: an interdisciplinary approach
Year: 2019
TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Year: 2021
Characterisation of post-pneumonectomy lung growth in adult mice
Source: Eur Respir J 2004; 24 : 524-532
Year: 2004
Curcumin inhibits COPD-like airway inflammation and lung cancer promotion in mice
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Bone morphogenetic protein 9 protects against neonatal hyperoxia-induced impairment of lung development, inflammation and fibrosis.
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept